Skip to main content
Caplight Logo









Symbiome

Symbiome

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://symbiome.com/

Last Round

VC Round

Oct 31, 2022

Total Funding Raised

$18M

Company Overview

Symbiome is a skincare company that produces science-based, microbiome-focused beauty products using sustainably sourced Amazonian ingredients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

microbiome skincareskin microbiomeclean beautypostbiotic skincareDTC skincaremicrobiome-friendlybiotech skincareskin healthancestral skincareskincare sciencedermatology-consciousclinical skincareskin barrier supportmicrobiome healthbiohacking beauty

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbiome Comparables

Compare Symbiome with similar companies based on industry and business-model similarity.

Symbiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AOBiome Therapeutics Inc.
83%
Glowbiotics
83%
Marie Veronique
81%

Symbiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 31, 2022
Series ASep 14, 2020
DebtJun 1, 2020

Key People

Founding team and executive leadership

Mads Hansen

Chief Product Officer

Executive Team

Symbiome Investors

Notable investors and investment history

Symbiome investors
InvestorRounds
GISEVSeries A
BOLD Capital PartnersSeries A
True VenturesPre Seed, Series A
Mission Bay CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 78% MoM, reaching 7.8K.

  • May 2, 2025

    Monthly visitors increased 76% to 15,000.

Symbiome Filings

Explore SEC and related filing metadata, where available.

Symbiome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Symbiome's valuation, stock price, and market status.

Is Symbiome a public or private company?

Symbiome is a private company.

What is the current stock price of Symbiome?

Symbiome is a private company with no public stock price. No recent secondary market data is available.

How much is Symbiome worth (valuation)?

Valuation information for Symbiome is not publicly available.

Can I buy Symbiome stock?

Symbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Symbiome's last funding round?

Symbiome's most recent funding round was VC Round on October 31, 2022.

Who are the main investors in Symbiome?

Key investors in Symbiome include True Ventures.

Will Symbiome IPO soon?

No public IPO plans have been announced for Symbiome.

How can I track Symbiome secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symbiome's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2017
Last FundingOct 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?